参考文献
［1］Arrojo E Drigo R，Ali Y，Diez J，et al.New insights into the architecture of the islet of Langerhans：a focused cross-species assessment.Diabetologia，2015，58（10）：2218-2228.
［2］Jennings R E，Berry A A，Strutt J P，et al.Human pancreas development.Development，2015，142（18）：3126-3137.
［3］Shih H P，Wang A，Sander M.Pancreas organogenesis：from lineage determination to morphogenesis.Annu Rev Cell Dev Biol，2013，29：81-105.
［4］Hard W L.The origin and differentiation of the alpha and beta cells in the pancreatic islets of the rat.American Journal of Anatomy，1944，75（3）：369-403.
［5］Cole L，Anderson M，Antin P B，et al.One process for pancreatic beta-cell coalescence into islets involves an epithelial-mesenchymal transition.J Endocrinol，2009，203（1）：19-31.
［6］Sharon N，Chawla R，Mueller J，et al.A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets.Cell，2019，176（4）：790-804.
［7］Larsen H L，Grapin-Botton A.The molecular and morphogenetic basis of pancreas organogenesis.Semin Cell Dev Biol，2017，66：51-68.
［8］Mcdole K，Guignard L，Amat F，et al.In toto imaging and reconstruction of post-implantation mouse development at the single-cell level.Cell，2018，175（3）：859-876.
［9］Sato T，Vries R G，Snippert H J，et al.Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche.Nature，2009，459（7244）：262-265.
［10］Greggio C，De Franceschi F，Figueiredo-Larsen M，et al.Artificial three-dimensional niches deconstruct pancreas development in vitro.Development，2013，140（21）：4452-4462.
［11］Sugiyama T，Benitez C M，Ghodasara A，et al.Reconstituting pancreas development from purified progenitor cells reveals genes essential for islet differentiation.Proc Natl Acad Sci U S A，2013，110（31）：12691-12696.
［12］Bakhti M，Scheibner K，Tritschler S，et al.Establishment of a high-resolution 3D modeling system for studying pancreatic epithelial cell biology in vitro.Mol Metab，2019，30：16-29.
［13］Bonfanti P，Nobecourt E，Oshima M，et al.Ex vivo expansion and differentiation of human and mouse fetal pancreatic progenitors are modulated by epidermal growth factor.Stem Cells Dev，2015，24（15）：1766-1778.
［14］Scavuzzo M A，Yang D，Borowiak M.Organotypic pancreatoids with native mesenchyme develop Insulin producing endocrine cells.Sci Rep，2017，7（1）：10810.
［15］Goncalves C A，Larsen M，Jung S，et al.A 3D system to model human pancreas development and its reference single-cell transcriptome atlas identify signaling pathways required for progenitor expansion.Nat Commun，2021，12（1）：3144.
［16］Loomans C J M，Williams Giuliani N，Balak J，et al.Expansion of adult human pancreatic tissue yields organoids harboring progenitor cells with endocrine differentiation potential.Stem Cell Reports，2018，10（3）：712-724.
［17］Huch M，Bonfanti P，Boj S F，et al.Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis.EMBO J，2013，32（20）：2708-2721.
［18］Boj S F，Hwang C I，Baker L A，et al.Organoid models of human and mouse ductal pancreatic cancer.Cell，2015，160（1-2）：324-338.
［19］Jin L，Feng T，Shih H P，et al.Colony-forming cells in the adult mouse pancreas are expandable in Matrigel and form endocrine/acinar colonies in laminin hydrogel.Proc Natl Acad Sci U S A，2013，110（10）：3907-3912.
［20］Lee J，Sugiyama T，Liu Y，et al.Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells.Elife，2013，2：e00940.
［21］Rezanejad H，Ouziel-Yahalom L，Keyzer C A，et al.Heterogeneity of SOX9 and HNF1beta in pancreatic ducts is dynamic.Stem Cell Reports，2018，10（3）：725-738.
［22］Rovira M，Scott S G，Liss A S，et al.Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas.Proc Natl Acad Sci U S A，2010，107（1）：75-80.
［23］Wollny D，Zhao S，Everlien I，et al.Single-cell analysis uncovers clonal acinar cell heterogeneity in the adult pancreas.Dev Cell，2016，39（3）：289-301.
［24］Wang D，Wang J，Bai L，et al.Long-term expansion of pancreatic islet organoids from resident procr（＋）progenitors.Cell，2020，180（6）：1198-1211.
［25］Qiu W L，Zhang Y W，Feng Y，et al.Deciphering pancreatic islet beta cell and alpha cell maturation pathways and characteristic features at the single-cell level.Cell Metab，2017，25（5）：1194-1205.
［26］Zhao H，Huang X，Liu Z，et al.Pre-existing beta cells but not progenitors contribute to new beta cells in the adult pancreas.Nat Metab，2021，3（3）：352-365.
［27］Murry C E，Keller G.Differentiation of embryonic stem cells to clinically relevant populations：lessons from embryonic development.Cell，2008，132（4）：661-680.
［28］D'amour K A，Agulnick A D，Eliazer S，et al.Efficient differentiation of human embryonic stem cells to definitive endoderm.Nat Biotechnol，2005，23（12）：1534-1541.
［29］Zhang D，Jiang W，Liu M，et al.Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells.Cell Res，2009，19（4）：429-438.
［30］Jiang W，Shi Y，Zhao D，et al.In vitro derivation of functional insulin-producing cells from human embryonic stem cells.Cell Res，2007，17（4）：333-344.
［31］Kroon E，Martinson L A，Kadoya K，et al.Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.Nat Biotechnol，2008，26（4）：443-452.
［32］D'amour K A，Bang A G，Eliazer S，et al.Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells.Nat Biotechnol，2006，24（11）：1392-1401.
［33］Nostro M C，Sarangi F，Ogawa S，et al.Stage-specific signaling through TGFbeta family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells.Development，2011，138（5）：861-871.(https://www.daowen.com)
［34］Pagliuca F W，Millman J R，Gurtler M，et al.Generation of functional human pancreatic beta cells in vitro.Cell，2014，159（2）：428-439.
［35］Rezania A，Bruin J E，Arora P，et al.Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells.Nat Biotechnol，2014，32（11）：1121-1133.
［36］Cheng X，Tiyaboonchai A，Gadue P.Endodermal stem cell populations derived from pluripotent stem cells.Curr Opin Cell Biol，2013，25（2）：265-271.
［37］Cheng X，Ying L，Lu L，et al.Self-renewing endodermal progenitor lines generated from human pluripotent stem cells.Cell Stem Cell，2012，10（4）：371-384.
［38］Huang L，Holtzinger A，Jagan I，et al.Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell-and patient-derived tumor organoids.Nat Med，2015，21（11）：1364-1371.
［39］Hohwieler M，Illing A，Hermann P C，et al.Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling.Gut，2017，66（3）：473-486.
［40］Breunig M，Merkle J，Wagner M，et al.Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells.Cell Stem Cell，2021，28（6）：1105-1124.
［41］Huang L，Desai R，Conrad D N，et al.Commitment and oncogene-induced plasticity of human stem cell-derived pancreatic acinar and ductal organoids.Cell Stem Cell，2021，28（6）：1090-1104.
［42］Takahashi Y，Sekine K，Kin T，et al.Self-condensation culture enables vascularization of tissue fragments for efficient therapeutic transplantation.Cell Rep，2018，23（6）：1620-1629.
［43］Nalbach L，Roma L P，Schmitt B M，et al.Improvement of islet transplantation by the fusion of islet cells with functional blood vessels.EMBO Mol Med，2021，13（1）：e12616.
［44］Aghazadeh Y，Poon F，Sarangi F，et al.Microvessels support engraftment and functionality of human islets and hESC-derived pancreatic progenitors in diabetes models.Cell Stem Cell，2021，28（11）：1936-1949.
［45］Balboa D，Barsby T，Lithovius V，et al.Functional，metabolic and transcriptional maturation of human pancreatic islets derived from stem cells.Nat Biotechnol，2022，40（7）：1042-1055.
［46］Veres A，Faust A L，Bushnell H L，et al.Charting cellular identity during human in vitro betacell differentiation.Nature，2019，569（7756）：368-373.
［47］Kim H，Toyofuku Y，Lynn F C，et al.Serotonin regulates pancreatic beta cell mass during pregnancy.Nat Med，2010，16（7）：804-808.
［48］Zhang X，Ma Z，Song E，et al.Islet organoid as a promising model for diabetes.Protein Cell，2022，13（4）：239-257.
［49］Ma Q，Xiao Y，Xu W，et al.Zn T8 loss-of-function accelerates functional maturation of h ESCderived beta cells and resists metabolic stress in diabetes.Nat Commun，2022，13（1）：4142.
［50］Amin S，Cook B，Zhou T，et al.Discovery of a drug candidate for GLIS3-associated diabetes.Nat Commun，2018，9（1）：2681.
［51］Gonzalez F，Zhu Z，Shi Z D，et al.An iCRISPR platform for rapid，multiplexable，and inducible genome editing in human pluripotent stem cells.Cell Stem Cell，2014，15（2）：215-226.
［52］Lee K，Cho H，Rickert R W，et al.FOXA2 is required for enhancer priming during pancreatic differentiation.Cell Rep，2019，28（2）：382-393.
［53］Shi Z D，Lee K，Yang D，et al.Genome editing in hPSCs reveals GATA6 haploinsufficiency and a genetic interaction with GATA4 in human pancreatic development.Cell Stem Cell，2017，20（5）：675-688.
［54］Yang D，Cho H，Tayyebi Z，et al.CRISPR screening uncovers a central requirement for HHEX in pancreatic lineage commitment and plasticity restriction.Nat Cell Biol，2022，24（7）：1064-1076.
［55］Zhu Z，Li Q V，Lee K，et al.Genome editing of lineage determinants in human pluripotent stem cells reveals mechanisms of pancreatic development and diabetes.Cell Stem Cell，2016，18（6）：755-768.
［56］Hermann F M，Kjaergaard M F，Tian C，et al.An insulin hypersecretion phenotype precedes pancreatic beta cell failure in MODY3 patient-specific cells.Cell Stem Cell，2023，30（1）：38-51.
［57］Leite N C，Sintov E，Meissner T B，et al.Modeling type 1 diabetes in vitro using human pluripotent stem cells.Cell Rep，2020，32（2）：107894.
［58］Armitage L H，Stimpson S E，Santostefano K E，et al.Use of induced pluripotent stem cells to build isogenic systems and investigate type 1 diabetes.Front Endocrinol（Lausanne），2021，12：737276.
［59］Nathan D M.Realising the long-term promise of insulin therapy：the DCCT/EDIC study.Diabetologia，2021，64（5）：1049-1058.
［60］Battelino T，Danne T，Bergenstal R M，et al.Clinical targets for continuous glucose monitoring data interpretation：Recommendations from the international consensus on time in range.Diabetes Care，2019，42（8）：1593-1603.
［61］Lablanche S，Vantyghem M C，Kessler L，et al.Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation（TRIMECO）：A multicentre，randomised controlled trial.Lancet Diabetes Endocrinol，2018，6（7）：527-537.
［62］Hampton R F，Jimenez-Gonzalez M，Stanley S A.Unravelling innervation of pancreatic islets.Diabetologia，2022，65（7）：1069-1084.
［63］Gjorevski N，Nikolaev M，Brown T E，et al.Tissue geometry drives deterministic organoid patterning.Science，2022，375（6576）：eaaw9021.
［64］Tao T，Deng P，Wang Y，et al.Microengineered multi-organoid system from hiPSCs to recapitulate human liver-islet Axis in normal and type 2 diabetes.Adv Sci（Weinh），2022，9（5）：e2103495.
［65］Zandi Shafagh R，Youhanna S，Keulen J，et al.Bioengineered pancreas-liver crosstalk in a microfluidic coculture chip identifies human metabolic response signatures in prediabetic hyperglycemia.Adv Sci（Weinh），2022，9（34）：e2203368.